(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/crwe_tech.jpg

Your Technology Source, Your Technology Team

Server Maintenance, Web Development, Mobile Application Solutions, SEO Services and more

Contact Us: contact@crwetech.com

www.CRWETech.com

ad2

http://crweworld.com/assets/images/ad/ad4.png

Place Your Ad Here! Advertise your business online on CRWE WORLD. Your Company, product, or service in front of the world!

Contact Us: contact@crweworld.com

www.CRWEWorld.com

ad3

http://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

http://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com

ad5

http://crweworld.com/assets/images/ad/Pathology_Laboratories.png

Quest Diagnostics Inc. (NYSE:DGX) offers the most extensive clinical testing network in the U.S. The Company's extensive test menu includes routine biological testing; complex and specialized molecular and gene-based testing, and anatomic pathology testing. These services primarily help identify disease or risk factors for disease and predict and monitor response to treatment.

www.QuestDiagnostics.com






1602 Result: Securities and Exchange Commission

Pluristem Reports Second Quarter Fiscal 2017 Highlights & Provides Calendar 2017 Outlook

February 13th, 2017

HAIFA, Israel / CRWE PRESS RELEASE / February 13, 2017 - Pluristem Therapeutics Inc. (Nasdaq: PSTI, TASE: PSTI), a leading developer of placenta-based cell therapy products, today reported financial update and corporate and clinical developments for . Read more

Kitov Provides Further Update on Formal Investigation by Israeli Securities Authority

February 09th, 2017

Tel Aviv, Israel / CRWE PRESS RELEASE / February 9, 2017 - Kitov Pharmaceuticals Holdings Ltd. (NASDAQ: KTOV; TASE: KTOV), an innovative biopharmaceutical company, in response to requests made by the NASDAQ Stock Market, today provided a further upda. Read more

Aehr Test Systems Receives Order from Subcontractor to Lead Customer for its FOX-XP(TM) Test and Burn-in System Products

February 08th, 2017

Fremont, CA / CRWE PRESS RELEASE / February 8, 2017 - Aehr Test Systems (NASDAQ: AEHR), a worldwide supplier of semiconductor test and burn-in equipment, today announced that it has received an order from a subcontractor to its lead customer for its . Read more

Qualcomm Extends Cash Tender Offer for All Outstanding Shares of NXP

February 06th, 2017

- NXP Shareholders Approve All Items Proposed Relating To Qualcomm’s Tender Offer - SAN DIEGO / CRWE PRESS RELEASE / Feb. 6, 2017 - Qualcomm Incorporated (NASDAQ: QCOM) today announced that Qualcomm River Holdings B.V. , an indirect wholly o. Read more

Walgreens Boots Alliance and Rite Aid Enter into Amendment and Extension to Merger Agreement

January 30th, 2017

Deerfield, Ill. and Camp Hill, Pa. / CRWE PRESS RELEASE / January 30, 2017 - Walgreens Boots Alliance, Inc. (Nasdaq: WBA) and Rite Aid Corporation (NYSE: RAD) today announced that they have entered into an amendment and extension of their previously . Read more

Fuel Tech Awarded Air Pollution Control Orders Totaling $5.0 Million

January 30th, 2017

WARRENVILLE, Ill. / CRWE PRESS RELEASE / January 30, 2017 - Fuel Tech, Inc. (NASDAQ:FTEK), a world leader in advanced engineering solutions for the optimization of combustion systems and emissions control in utility and industrial applications, today. Read more

DHT Holdings, Inc. Announces Receipt of Non-binding Proposal, Adopts One-Year Shareholder Rights Plan

January 29th, 2017

HAMILTON, BERMUDA / CRWE PRESS RELEASE / January 29, 2017 - DHT Holdings, Inc. (NYSE: DHT) today announced that it has received a non-binding, highly conditional proposal from Frontline Ltd. (NYSE/OSE: FRO) to acquire all of the outstanding shar. Read more

Teck Announces Sale of Wintering Hills Wind Power Facility

January 26th, 2017

Calgary, AB / CRWE PRESS RELEASE / January 26, 2017 - Teck Resources Limited (“Teck”, TSX: TECK.A and TECK.B, NYSE: TECK) announced today that it has entered into an agreement to sell its 49 per cent interest in the Wintering Hi. Read more

Pluristem Announces Bought Deal Offering

January 19th, 2017

Haifa, Israel / CRWE PRESS RELEASE / January 19, 2017 - Pluristem Therapeutics Inc. (NASDAQCM: PSTI, TASE: PLTR) announced today that it has entered into an underwriting agreement with H.C. Wainwright & Co., LLC, under which the underwriter has agree. Read more

Ceragon Receives Over $60 Million in Orders for its IP-20 Platform from Tier 1 Mobile Operator in India to Support Rapid 4G Network Expansion

January 18th, 2017

Ceragon continues its role in significantly increasing 4G service coverage and network capacity Little Falls, New Jersey / CRWE PRESS RELEASE / January 18, 2017 - Ceragon Networks Ltd. (NASDAQ: CRNT), the #1 wireless backhaul specialist, toda. Read more

Pluristem Receives Clearance from Germany to Initiate its Multinational Phase III Trial in Critical Limb Ischemia Targeting Early Conditional Marketing Approval

January 17th, 2017

* PLX-PAD cells could potentially obtain early conditional marketing approval in Europe via the Adaptive Pathways pilot project based on positive interim efficacy data from first 125 patients * This approval joins those from the U.S. FDA and U.K. fo. Read more

Forward Pharma Agrees to Enter Into Settlement and License Agreement with Biogen

January 17th, 2017

* Biogen will pay Forward a non-refundable cash fee of $1.25 billion * Forward may be eligible to receive royalties of 10% of net sales of Tecfidera beginning in 2021, and of 20% of net sales beginning in 2029, depending on the outcome of certain . Read more

Globus Maritime Announces Update Regarding Private Placement

January 13th, 2017

Athens, Greece / CRWE PRESS RELEASE / January 13, 2017 - Globus Maritime Limited ("Globus," or the "Company"), (NASDAQ: GLBS), a dry bulk shipping company, announced today that its previously disclosed private placement and conversion of debt will no. Read more

Pluristem Completes Patient Enrollment in a Large Multinational Phase II Trial in Intermittent Claudication

January 12th, 2017

* Top line results from the 172-patient trial to be reported in early 2018 * Data to support Pluristem’s planned Biologics License Application for marketing approval of PLX-PAD in the U.S. and Europe * 14 million people in the U.S. are treate. Read more

Transgenomic Announces Leading Clinical Laboratory Services Provider LifeLabs Selects ICE COLD-PCR as its Mutation Enrichment Platform

January 12th, 2017

Three-Year Renewable Agreement Also Includes Non-Exclusive License to ICP in Canada New Patent Has Issued Covering ICE COLD-PCR Technology in Canada OMAHA, Neb. / CRWE PRESS RELEASE / January 12, 2017 - Transgenomic, Inc. (TBIO) (NASDAQ: . Read more

Load More Content